+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oncology Molecular Diagnostics Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5214715
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Diagnostics
  • BioRad
  • Cepheid
  • Gen Probe(Hologic)
  • Leica Biosystems
  • Qiagen N.V.
  • MORE
Oncology Molecular Diagnostics Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Molecular Diagnostics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.
Scope

Markets Covered:
1) By Product: Instruments; Reagents; Others
2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Others
3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Others

Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • BioRad
  • Cepheid
  • Gen Probe(Hologic)
  • Leica Biosystems
  • Qiagen N.V.
  • MORE
1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Size and Growth
3.1. Global Oncology Molecular Diagnostics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Oncology Molecular Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Oncology Molecular Diagnostics Market Segmentation
4.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Instruments
  • Reagents
  • Others
4.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Others
4.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others
5. Oncology Molecular Diagnostics Market Regional and Country Analysis
5.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Oncology Molecular Diagnostics Market
6.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
6.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Oncology Molecular Diagnostics Market
7.1. China Oncology Molecular Diagnostics Market Overview
7.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Oncology Molecular Diagnostics Market
8.1. India Oncology Molecular Diagnostics Market Overview
8.2. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Oncology Molecular Diagnostics Market
9.1. Japan Oncology Molecular Diagnostics Market Overview
9.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Oncology Molecular Diagnostics Market
10.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Oncology Molecular Diagnostics Market
11.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Oncology Molecular Diagnostics Market
12.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Oncology Molecular Diagnostics Market
13.1. Western Europe Oncology Molecular Diagnostics Market Overview
13.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Oncology Molecular Diagnostics Market
14.1. UK Oncology Molecular Diagnostics Market Overview
14.2. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Oncology Molecular Diagnostics Market
15.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Oncology Molecular Diagnostics Market
16.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Oncology Molecular Diagnostics Market
17.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
17.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Oncology Molecular Diagnostics Market
18.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Oncology Molecular Diagnostics Market
19.1. North America Oncology Molecular Diagnostics Market Overview
19.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Oncology Molecular Diagnostics Market
20.1. USA Oncology Molecular Diagnostics Market Overview
20.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Oncology Molecular Diagnostics Market
21.1. South America Oncology Molecular Diagnostics Market Overview
21.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Oncology Molecular Diagnostics Market
22.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Oncology Molecular Diagnostics Market
23.1. Middle East Oncology Molecular Diagnostics Market Overview
23.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Oncology Molecular Diagnostics Market
24.1. Africa Oncology Molecular Diagnostics Market Overview
24.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Oncology Molecular Diagnostics Market Competitive Landscape and Company Profiles
25.1. Oncology Molecular Diagnostics Market Competitive Landscape
25.2. Oncology Molecular Diagnostics Market Company Profiles
25.2.1. Abbott Diagnostics
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Becton Dickinson
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Cepheid
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Danaher Corporation
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Beckman Coulter
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions In The Oncology Molecular Diagnostics Market

27. Oncology Molecular Diagnostics Market Trends and Strategies

28. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • BioRad
  • Cepheid
  • Gen Probe(Hologic)
  • Leica Biosystems
  • Qiagen N.V.
  • MORE
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare.

The global oncology molecular diagnostics market is expected to decline from $5.58 billion in 2019 to $5.25 billion in 2020 at a compound annual growth rate (CAGR) of -5.81%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.41 billion in 2023 at a CAGR of 12.13%.

The oncology molecular diagnostics market consists of sales of molecular diagnostic instruments, kits and reagents used for diagnosing cancers and related services by entities (organizations, sole traders and partnerships) that produce molecular diagnostic equipment for diagnosing cancer. Molecular diagnostics are tests that diagnose genetic information, proteins or related molecules and provide health or disease information. This study is most usually performed on blood, saliva, or tumor tissue samples.

North America was the largest region in the oncology molecular diagnostics market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

In February 2019, ICON plc, a US-based biotechnology company, acquired MolecularMD for an undisclosed amount. The acquisition enhances ICON’s laboratory offering in molecular diagnostic testing and brings to ICON expanded testing platforms, including next-generation sequencing, and immunohistochemistry (IHC). MolecularMD is a US-based molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology.

The oncology molecular diagnostics market covered in this report is segmented by product into instruments; reagents; others. It is also segmented by technology into polymerase chain reaction (PCR); in-situ hybridization (ISH); isothermic nucleic acid amplification technology (INNAT); chips & microarrays; sequencing; mass spectroscopy; transcription mediated amplification (TMA); others and by end-user into hospitals; diagnostic centers; academic & research institutes; others.

The high cost of molecular diagnostic tests is a key factor hampering the growth of the oncology molecular diagnostics market. The cost of molecular diagnostic testing is comparatively higher in cancer care and it also depends on the type of therapy. For example, the cost of the molecular diagnostic test for non-small cell lung cancer monotherapy costs about $10,000 to $20,000 per month, and these costs are expected to increase in combination therapy. Therefore, the high cost of molecular diagnostic tests is expected to hamper the growth of the oncology molecular diagnostics market.

The advanced technology in genomics is a key trend in the oncology molecular diagnostics market. Advancements in cancer genome sequencing technology, computational analysis, tumor models, and innovation of modern cancer research methods promote early detection of cancer and its mutation. For instance, Roche Molecular Systems, Inc., a US-based company, developed Cobas EGFR Mutation Test for non-small cell lung cancer patients. This test is a real-time test that detects 42 mutations of the epidermal growth factor receptor (EGFR) gene, along with the resistant mutation of cancer. In June 2020, FDA approved Cobas EGFR Mutation Test.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology molecular diagnostics market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the oncology molecular diagnostic market over the coming years.
Note: Product cover images may vary from those shown
4 of 5
  • Abbott Diagnostics
  • Becton Dickinson
  • Cepheid
  • Danaher Corporation
  • Beckman Coulter
  • Leica Biosystems
  • Gen Probe(Hologic)
  • Qiagen N.V.
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex Corporation
  • BioRad
  • Illumina, Inc.
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • OPKO Health, Inc.
  • Pacific Biosciences of California, Inc. (PacBio)
  • Bio-Techne
  • Cancer Genetics
  • Charles River
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll